Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

Clinical trial NCT05348668 · COMPLETED

Trial details

NCT number: NCT05348668
Sponsor: Anhui Provincial Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2022-05-09
Primary completion: 2025-03-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.